14:20 EDT Syndax (SNDX) trading resumes
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNDX:
- Syndax confirms FDA approves second indication for Revuforj
- FDA approves Syndax’s revumenib for relapsed or refractory AML
- Syndax trading halted, news pending
- Syndax assumed with a Buy at H.C. Wainwright
- Strategic Positioning and Competitive Edge: Syndax Pharmaceuticals’ Buy Rating Reinforced by Revuforj’s Milestones in Leukemia Treatment